What is the official website of Prevail Therapeutics ?

The official website of Prevail Therapeutics is http://www.prevailtherapeutics.com.

What is Prevail Therapeutics's cybersecurity risk score?

Prevail Therapeutics has an AI-generated cybersecurity risk score of 753 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Prevail Therapeutics experienced?

According to Rankiteo, Prevail Therapeutics currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Prevail Therapeutics been affected by any supply chain cyber incidents ?

According to Rankiteo, Prevail Therapeutics has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Prevail Therapeutics have SOC 2 Type 1 certification ?

According to Rankiteo, Prevail Therapeutics is not certified under SOC 2 Type 1.

Does Prevail Therapeutics have SOC 2 Type 2 certification ?

According to Rankiteo, Prevail Therapeutics does not hold a SOC 2 Type 2 certification.

Does Prevail Therapeutics comply with GDPR ?

According to Rankiteo, Prevail Therapeutics is not listed as GDPR compliant.

Does Prevail Therapeutics have PCI DSS certification ?

According to Rankiteo, Prevail Therapeutics does not currently maintain PCI DSS compliance.

Does Prevail Therapeutics comply with HIPAA ?

According to Rankiteo, Prevail Therapeutics is not compliant with HIPAA regulations.

Does Prevail Therapeutics have ISO 27001 certification ?

According to Rankiteo,Prevail Therapeutics is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Prevail Therapeutics operate in ?

Prevail Therapeutics operates primarily in the Biotechnology industry.

How many employees does Prevail Therapeutics have ?

Prevail Therapeutics employs approximately 19 people worldwide.

Does Prevail Therapeutics own any subsidiaries ?

Prevail Therapeutics presently has no subsidiaries across any sectors.

How many LinkedIn followers does Prevail Therapeutics have ?

Prevail Therapeutics's official LinkedIn profile has approximately 12,815 followers.

Does Prevail Therapeutics have a Crunchbase profile ?

Yes, Prevail Therapeutics has an official profile on Crunchbase, which can be accessed here: https://www.crunchbase.com/organization/prevail-therapeutics.

Does Prevail Therapeutics have a LinkedIn profile ?

Yes, Prevail Therapeutics maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/prevail-therapeutics.

How many cybersecurity incidents has Prevail Therapeutics experienced ?

As of August 24, 2026, Rankiteo reports that Prevail Therapeutics has not experienced any cybersecurity incidents.

How many peer or competitor companies does Prevail Therapeutics have ?

Prevail Therapeutics has an estimated 1,077 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Prevail Therapeutics

Boost Score +25 with badge (5 left)

753

/1000

Fair

778

/1000

Fair

Prevail Therapeutics Vendor Cyber Rating & Cyber Score

prevailtherapeutics.com

cb in

Add Your Compliance Badge

At Prevail Therapeutics, we are developing novel gene therapies that target the root genetic causes of Parkinson’s disease and other neurodegenerative disorders. Our mission is to translate recent advances in human genetics and gene therapy technology into medicines that slow or stop the neurodegenerative process. Our programs utilize a precision medicine approach targeting patient populations with urgent unmet needs, where there are currently no available therapies that modify the progressive course of their disorders. Prevail was formed in 2017 and we are building a team of dedicated, creative and talented individuals who share our passion for serving patients with neurodegenerative diseases. We pride ourselves on following great

Prevail Therapeutics A.I CyberSecurity Scoring

Scoring History

Prevail Therapeutics

Prevail Therapeutics CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

Prevail Therapeutics Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Prevail Therapeutics

Incidents vs Biotechnology Industry Avg (This Year)

No incidents recorded for Prevail Therapeutics in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Prevail Therapeutics in 2026.

Incident Types Prevail Therapeutics vs Biotechnology Industry Avg (This Year)

No incidents recorded for Prevail Therapeutics in 2026.

Incident History - Prevail Therapeutics (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Prevail Therapeutics Subsidiaries

Parent Company

Prevail Therapeutics

Biotechnology

Website: http://www.prevailtherapeutics.com

Company Size: 51-200 employees

No subsidiary data available for this company.

Loading…

Prevail Therapeutics Similar Companies

Regeneron

cb regeneron.com

At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in. Please visit www.regeneron.com/social-media-terms for information on how to engage with us on social media. An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media.

Loading…

NEWS

Prevail Therapeutics CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

May 06, 2025 07:00 AM

Eli Lilly signs $415m deal for Alchemab’s ALS therapy

UK-based Alchemab has secured a licensing agreement worth up to $415m with Eli Lilly for ATLX-1282, its investigational antibody therapy targeting amyotrophic...

Read Article

February 01, 2025 08:00 AM

Capsida's AAV platform nets $40M AbbVie milestone payment

Capsida Biotherapeutics, a gene therapy startup that has quietly amassed a network of Big Pharma partnerships, announced in January that its partner AbbVie...

Read Article

March 28, 2024 07:00 AM

CRISPR drug licensing deals secure $21bn in top three therapy areas over five years

CRISPR technologies saw oncology, immunology, and central nervous system as the top three therapy areas by total deal value with a combined $21bn over the past...

Read Article

October 18, 2022 07:00 AM

Eli Lilly to buy gene therapy company Akouos for $487 mln

Eli Lilly and Co will acquire genetic medicine developer Akouos Inc for about $487 million in cash as the drugmaker aims to bolster its...

Read Article

February 22, 2022 08:00 AM

Lilly invests $700M in Boston Seaport site

Eli Lilly and Company will spend roughly $700 million to build the Lilly Institute for Genetic Medicine in Boston's Seaport neighborhood.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-78147

SUMMARY

A vulnerability was found in ggml-org llama.cpp bec4772f6. The impacted element is the function deserialize_tensor of the file ggml/src/ggml-rpc/ggml-rpc.cpp of the component ggml-RPC Server. Performing a manipulation of the argument op/op_params results in deserialization. The attack may be initiated remotely. This vulnerability is distinct from CVE-2026-34159 (GHSA-j8rj-fmpv-wcxw, PR #20908), which only added a buffer==nullptr rejection in create_node() and does not validate op or op_params. The reported GitHub issue was closed automatically due to inactivity.

Published

Date2026-08-23

Updated

Date2026-08-23

RISK INFORMATION (Score: 7.3)

cvss2

Base Score: 7.5

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:P/A:P

cvss3

Base Score: 7.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 6.9

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

3.9

REFERENCES

CVE-2026-78145

SUMMARY

A vulnerability has been found in CTFd up to 3.8.4. The affected element is the function _is_safe_url of the file CTFd/utils/validators/__init__.py. Such manipulation of the argument Next leads to open redirect. The attack can be launched remotely. The exploit has been disclosed to the public and may be used. The name of the patch is 5d8515842fd1ab2c3a9f2dde9ffca907aa334ea9. Upgrading the affected component is recommended.

Published

Date2026-08-23

Updated

Date2026-08-23

RISK INFORMATION (Score: 4.3)

cvss2

Base Score: 5.0

Complexity: LOW

AV:N/AC:L/Au:N/C:N/I:P/A:N

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:N

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

2.8

REFERENCES

CVE-2026-78144

SUMMARY

A vulnerability was identified in code-projects Barangay Resident Profiling Management System 1.0. Affected by this vulnerability is an unknown functionality of the file /boarders.php of the component Boarder Management Module. Such manipulation of the argument ID leads to authorization bypass. The attack can be executed remotely. The exploit is publicly available and might be used.

Published

Date2026-08-23

Updated

Date2026-08-23

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-78143

SUMMARY

A vulnerability was determined in code-projects Barangay Resident Profiling Management System 1.0. Affected is an unknown function of the file residents.php of the component Resident Search Functionality. This manipulation of the argument Search causes sql injection. Remote exploitation of the attack is possible. The exploit has been publicly disclosed and may be utilized.

Published

Date2026-08-23

Updated

Date2026-08-23

RISK INFORMATION (Score: 7.3)

cvss2

Base Score: 7.5

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:P/A:P

cvss3

Base Score: 7.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 5.5

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

3.9

REFERENCES

CVE-2026-78142

SUMMARY

A vulnerability was found in code-projects Barangay Resident Profiling Management System 1.0. This impacts an unknown function of the file /archived_records.php of the component Restore/Delete. The manipulation of the argument resident_id results in authorization bypass. The attack may be launched remotely. The exploit has been made public and could be used.

Published

Date2026-08-23

Updated

Date2026-08-23

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…